Synchrotron X-Ray Boost Delivered by Microbeam Radiation Therapy After Conventional X-Ray Therapy Fractionated in Time Improves F98 Glioma Control.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 05 09 2019
revised: 29 01 2020
accepted: 02 02 2020
pubmed: 24 2 2020
medline: 13 2 2021
entrez: 24 2 2020
Statut: ppublish

Résumé

Synchrotron microbeam radiation therapy (MRT) is based on the spatial fractionation of the incident, highly collimated synchrotron beam into arrays of parallel microbeams depositing several hundred grays. It appears relevant to combine MRT with a conventional treatment course, preparing a treatment scheme for future patients in clinical trials. The efficiency of MRT delivered after several broad-beam (BB) fractions to palliate F98 brain tumors in rats in comparison with BB fractions alone was evaluated in this study. Rats bearing 10 MRT-boosted tumors displayed lower cell density and cell proliferation compared with BB-irradiated tumors. The MRT boost completely stopped tumor growth during ∼4 weeks and led to a significant increase in median survival time, whereas tumors treated with BB alone recurred within a few days after the last radiation fraction. The first evidence is presented that MRT, delivered as a boost of conventionally fractionated irradiation by orthovoltage broad x-ray beams, is feasible and more efficient than conventional radiation therapy alone.

Identifiants

pubmed: 32088292
pii: S0360-3016(20)30222-4
doi: 10.1016/j.ijrobp.2020.02.023
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-369

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Marine Potez (M)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France.

Audrey Bouchet (A)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France; Institute of Anatomy, Group Tomographic and Clinical Anatomy, University of Bern, Bern, Switzerland. Electronic address: audrey.bouchet@inserm.fr.

Mélanie Flaender (M)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France.

Claire Rome (C)

Team Functional NeuroImaging and Brain Perfusion, Inserm, France; Grenoble Institut des Neurosciences, Université Grenoble Alpes, La Tronche, France.

Nora Collomb (N)

Team Functional NeuroImaging and Brain Perfusion, Inserm, France; Grenoble Institut des Neurosciences, Université Grenoble Alpes, La Tronche, France.

Michael Grotzer (M)

Department of Oncology, University Children's Hospital of Zurich, Switzerland.

Michael Krisch (M)

European Synchrotron Radiation Facility, Grenoble, France.

Valentin Djonov (V)

Institute of Anatomy, Group Tomographic and Clinical Anatomy, University of Bern, Bern, Switzerland.

Jacques Balosso (J)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France.

Emmanuel Brun (E)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France.

Jean A Laissue (JA)

University of Bern, Bern, Switzerland.

Raphaël Serduc (R)

Inserm UA7, Rayonnement synchrotron pour la recherche médicale (STROBE), Université Grenoble Alpes, Grenoble, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH